- Home
- SABS vs CETY Comparison
SABS vs CETY Comparison
Compare SABS & CETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- CETY
- Stock Information
- Founded
- SABS 2014
- CETY 1993
- Country
- SABS United States
- CETY United States
- Employees
- SABS N/A
- CETY N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- CETY Power Generation
- Sector
- SABS Health Care
- CETY Utilities
- Exchange
- SABS Nasdaq
- CETY Nasdaq
- Market Cap
- SABS 15.8M
- CETY 17.0M
- IPO Year
- SABS N/A
- CETY N/A
- Fundamental
- Price
- SABS $2.28
- CETY $0.24
- Analyst Decision
- SABS Strong Buy
- CETY
- Analyst Count
- SABS 5
- CETY 0
- Target Price
- SABS $10.00
- CETY N/A
- AVG Volume (30 Days)
- SABS 85.9K
- CETY 293.5K
- Earning Date
- SABS 11-05-2025
- CETY 08-19-2025
- Dividend Yield
- SABS N/A
- CETY N/A
- EPS Growth
- SABS N/A
- CETY N/A
- EPS
- SABS N/A
- CETY N/A
- Revenue
- SABS $114,698.00
- CETY $1,743,723.00
- Revenue This Year
- SABS N/A
- CETY N/A
- Revenue Next Year
- SABS N/A
- CETY N/A
- P/E Ratio
- SABS N/A
- CETY N/A
- Revenue Growth
- SABS N/A
- CETY N/A
- 52 Week Low
- SABS $1.00
- CETY $0.20
- 52 Week High
- SABS $6.60
- CETY $1.27
- Technical
- Relative Strength Index (RSI)
- SABS 54.42
- CETY 45.64
- Support Level
- SABS $2.03
- CETY $0.24
- Resistance Level
- SABS $2.34
- CETY $0.25
- Average True Range (ATR)
- SABS 0.12
- CETY 0.01
- MACD
- SABS 0.02
- CETY -0.00
- Stochastic Oscillator
- SABS 84.00
- CETY 13.16
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About CETY Clean Energy Technologies Inc.
Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business. It has four segments: Clean Energy HRS & CETY Europe, CETY Renewables Waste to Energy Solutions, Engineering and Manufacturing Business and CETY HK. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.